Reversible immortalization of human myogenic cells by site-specific excision of a retrovitally transferred oncogene

Human Gene Therapy

Volumn 10, Issue 10, 1999, Pages 1607-1617

  Berghella, L ^a   De Angelis, L ^a   Coletta, M ^a   Berarducci, B ^a   Sonnino, C ^a   Salvatori, G ^a,b   Anthonissen, C ^a   Cooper, R ^c   Butler Browne, G S ^c   Mouly, V ^c   Ferrari, G ^d   Mavilio, F ^d   Cossu, G ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Sigma Tau   (Italy)

^c CNRS   (France)

^d SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS LARGE T ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL IMMORTALIZATION; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; VIRUS ONCOGENE;

3T3 CELLS; ADULT; ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; CELL DIFFERENTIATION; CELL DIVISION; CELL TRANSFORMATION, VIRAL; CELLS, CULTURED; CHILD, PRESCHOOL; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; INTEGRASES; MICE; MOLONEY MURINE LEUKEMIA VIRUS; MUSCLES; ONCOGENES; VIRAL PROTEINS;

EID: 0033166880     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950017617     Document Type: Article

References (41)

1. ABDALLAH, B., HASSAN, A., BENIST, C., GOULA, D., BEHR, J.P., and DEMENEIX, B. (1996). A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: Polyethylenimine. Hum. Gene Ther. 7, 1947-1954.
2. ABRAMIAN, D.S., ROMANOV, S.R., SMAGINA, L.V., and GLEBOV, O.K. (1994). Agents that act on chromatin structure affect the rate of intrachromosomal homologous DNA recombination in cultured cells. Tsitologiia 36, 1012-1021.
3. ANTON, M., and GRAHAM, F. (1995). Site-specific recombination mediated by an adenovirus vector expressing the Cre recombinase protein: A molecular switch for control of gene expression. J. Virol. 69(8), 4600-4606.
4. BADER, D., MASAKI, T., and FISCHMAN, D.A. (1982). Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro. J. Cell Biol. 95, 763-770.
5. BENN, P.A. (1976). Specific chromosome aberrations in senescent fibroblast cell lines derived from human embryos. Am. J. Hum. Genet. 28, 465-473.
6. BONINI, C., FERRARI, G., VERZELLETTI, S., SERVIDA, P., ZAPPONE, E., RUGGIERI, L., PONZONI, M., ROSSINI, S., MAVILIO, F., TRAVERSARI, C., and BORDIGNON, C. (1997). HSV-TK gene transfer into donor lymphocytes for control of allogenic graft-versus-leukemia. Science 276, 1719-1724.
7. CHEN, W.Y., BAILEY, E.C., MCCUNE, S.L., DONG, J.Y., and TOWNES, T.M. (1997). Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase. Proc. Natl. Acad. Sci. U.S.A. 94, 5798-5803.
8. COUNTER, C.M., AVILION, A.A., LEFEUVRE, C.E., STEWART, N.G., GREIDER, C.W., HARLEY, C.B., and BACCHETTI, S. (1992). Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11, 1921-1929.
9. CRISTOFALO, V.J. (1988). Cellular biomarkers of aging. Exp. Gerontol. 23, 297-305.
10. DE CAPRIO, J.A., LUDLOW, J.W., FIGGE, J., SHEW, J.Y., HUANG, C.M., LEE, W.H., MARSILIO, E., PAUCHA, E., and LIVINGSTONE, D.M. (1988). SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54, 275-283.
11. DECARY, S., MOULY, V., and BUTLER-BROWNE, G.S. (1996). Telomere length as a tool to monitor myogenic cell amplification for cell-mediated gene therapy. Hum. Gene Ther. 7, 1347-1350.
12. DECARY, S., MOULY, V., BEN HAMIDA, C., SAUTET, A., BARBET, J.P., and BUTLER-BROWNE, G.S. (1997). Replicative potential and telomere length in human skeletal muscle: Implications for myogenic cell-mediated gene therapy. Hum. Gene Ther. 8, 1429-1438.
13. FERRARI, G., CUSELLA, DE ANGELIS, M.G., COLETTA, M., STORNAIOULO, A., PAOLUCCI, E., COSSU, G., and MAVILIO, F. (1998). Skeletal muscle regeneration by bone marrow derived myogenic progenitors. Science 279, 1528-1530.
14. FOGEL, M., and DEFENDI, V. (1967). Infection of muscle cultures from various species with oncogenic DNA viruses (SV40 and polyoma) Proc. Acad. Sci. U.S.A. 58, 967-973.
15. GUERETTE, D., SKUK, D., CELESTIN, F., HUARD, J.C., TARDIF, F., ASSELIN, I., ROY, M., GOULET, R., ROY, R., ENTMAN, M., and TREMBLAY, J.P. (1997). Prevention by anti-LFA-1 of acute myoblast death following transplantation. J. Immunol. 159, 2522-2531.
16. GUY, S., SCHNEIDER, J.W., CONDORELLI, G., KAUSHAI, S., MAHDAVI, V., and NADAL-GINARD, B. (1993). Interaction of myogenic factor and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72, 309-324.
17. HUARD, J., VERREAULT, S., ROY, R., TREMBLAY, M., and TREMBLAY, J.P. (1994). High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice. J. Clin. Invest. 93, 586-599.
18. JAT, P.S., and SHARP, P.A. (1989). Cell lines established by a temperature-sensitive simian virus 40 large T-antigen gene are growth restricted at the nonpermissive temperature. Mol. Cell. Biol. 9, 1672-1681.
19. KINOSHITA, I., VILQUIN, J.T., GUERETTE, B., ASSELIN, I., ROY, R., and TREMBLAY, J.P. (1994). Very efficient myoblast allotransplantation in mice under FK-506 immunosuppression. Muscle Nerve 17, 1407-1415.
20. LATTANZI, L., SALVATORI, G., COLETTA, M., SONNINO, C., CUSELLA DE ANGELIS, G., GIOGLIO, L., MURRY, C.E., KELLY, R., FERRARI, G., MOLINARO, M., CRESCENZI, M., MAVILIO, F., and COSSU, G. (1998). High efficiency myogenic conversion of human fibroblast by adenoviral vector-mediated MyoD gene transfer. J. Clin. Invest. 101(10), 2119-2128.
21. MANFREDI, J.J., and PRIVES, C. (1994). The transforming activity of simian virus 40 large tumor antigen. Biochim. Biophys. Acta 1198, 65-83.
22. MARKOWITZ, D., GOFF, S., and BANK, A. (1988). A safe packaging line for gene transfer: Separating vira genes on two different plasmids. J. Virol. 62, 1120-1124.
23. MILLER, A.D., and ROSMAN, G.J. (1989). Improved retroviral vector for gene transfer and expression. BioTechniques 7, 980-990.
24. MORGAN, J.E., BEAUCHAMP, J.R., PAGEL, C.N., PECKAM, M., ATALIOTIS, P., JAT, P.S., NOBLE, M.D., FARMER, K., and PARTRIDGE, T.A. (1994). Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: A model system for the derivation of tissue-specific and mutation-specific cell lines. Dev. Biol. 162, 486-498.
25. MOULY, V., EDOM, F., DECARY, S., VICART, J.P., BARBET, J.P., and BUTLER-BROWNE, G.S. (1996). SV40 large T antigen interferes with adult myosin heavy chain expression, but not with differentiation of human myogenic cells. Exp. Cell Res. 255, 268-276.
26. O'GORMAN, S., FOX, D.T., and WALH, G.M. (1991). Recombinase-mediated gene activation and site-specific integration in mammalian cells. Science 251, 1351-1355.
27. PARTRIDGE, T.A. (1996). Myoblast transplantation. In Yearbook of Cell and Tissue Transplantation. R.P. Lanza and W.L. Click, eds. (Kluwer Academic Publishers, London, UK) pp. 53-59.
28. RAY, F.A., MEYNE, J., and KRAEMER, P.M. (1992). SV40 T antigen induced chromosomal changes reflect a process that is both clastogenic and aneuploidogenic and is ongoing throughout neoplastic progression of human fibroblast. Mutat. Res. 284, 265-273.
29. RUGGIERI, L., AIUTI, A., SALAMONI, M., ZAPPONE, E., FERRARI, G., anD BORDIGNON, C. (1997). Cell-surface marking of CD (34+)-restricted phenotypes of human hematopoietic progenitor cells by retrovirus-mediated gene transfer. Hum. Gene Ther. 8, 1611.
30. SALVATORI, G., FERRARI, G., MEZZOGIORNO, A., SERVIDEI, S., COLETTA, M., TONALI, P., GIAVAZZI, R., COSSU, G., and MAVILIO, F. (1993). Retroviral vector-mediated gene transfer into human primary myogenic cells leads to expression in muscle fibers in vivo. Hum. Gene Ther. 4, 713-723.
31. SALVATORI, G., LATTANZI, L., PURI, P.L., MELCHIONNA, R., FIERI, C., LEVRERO, M., MOLINARO, M., and COSSU, G. (1997). A temperature-conditional mutant of simian virus 40 large T antigen requires serum to inhibit myogenesis and does not induce DNA synthesis in myotubes. Cell Growth Different. 8, 157-164.
32. SAMBROOK, J., FRITSCH, E.F., anD MANIATIS, T. (1989). Molecular Cloning: A Laboratory Manual, 2nd Ed. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY).
33. SEUER, B., and HENDERSON, N. (1988). Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc. Natl. Acad. Sci. U.S.A. 85, 5166-5170.
34. SEUER, B., and HENDERSON, N. (1990). Targeted insertion of exogenous DNA into the eukaryotic genome by the Cre recombinase. New Biol. 2(5), 441-449.
35. TAJBAKHSH, S., VIVARELLI, E., CUSELLA-DE ANGELIS, M.G., ROCANCOURT, D., BUCKINGHAM, M., and COSSU, G. (1994). A population of myogenic cells derived from the mouse neural tube. Neuron 13, 813-821.
36. WANG, P., ANTON, M., GRAHAM, F.L., and BACCHETTI, S. (1995). High frequency recombination between loxP sites in human chromosomes mediated by an adenovirus vector expressing Cre recombinase. Somat. Cell Mol. Genet. 21(6), 429-441.
37. WEBSTER, C., and BLAU, H.M. (1990). Accelerated age-related decline in replicative life span of Duchenne muscular dystrophy myoblast: Implication for cell and gene therapy. Somat. Cell. Mol. Genet. 16, 557-565.
38. WESTERMAN, K., and LEBOULCH, P. (1996). Reversible immortalization of mammalian cells mediated by retroviral transfer and site-specific recombination. Proc. Natl. Acad. Sci. U.S.A. 88, 4626-4630.
39. WRIGHT, W.E., and SHAY, K. (1995). Time, telomeres and tumours: Is cellular senescence more than an anticancer mechanism? Trends Cell Biol. 5, 293-296.
40. YOSHIURA, K., KANAY, Y., OCHIAI, A., SHIMOYAMA, Y., and SUGIMURA, T. (1995). Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc. Natl. Acad. Sci. U.S.A. 92, 7416-7419.
41. ZHANG, L.H., and JENSSEN, D. (1994). Studies on intrachromosomal recombination in SP5/V79 Chinese hamster cells upon exposure to different agents related to carcinogenesis. Carcinogenesis 15, 2303-2310.